Ethic Inc. Cuts Stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Ethic Inc. decreased its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 27.0% in the fourth quarter, Holdings Channel.com reports. The firm owned 11,585 shares of the medical instruments supplier’s stock after selling 4,289 shares during the period. Ethic Inc.’s holdings in DENTSPLY SIRONA were worth $220,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Bank of New York Mellon Corp boosted its stake in shares of DENTSPLY SIRONA by 27.9% in the 4th quarter. Bank of New York Mellon Corp now owns 2,403,110 shares of the medical instruments supplier’s stock valued at $45,611,000 after purchasing an additional 523,692 shares in the last quarter. Charles Schwab Investment Management Inc. boosted its stake in shares of DENTSPLY SIRONA by 1.7% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 2,101,133 shares of the medical instruments supplier’s stock valued at $39,880,000 after purchasing an additional 35,360 shares in the last quarter. Barclays PLC boosted its position in DENTSPLY SIRONA by 21.8% during the 3rd quarter. Barclays PLC now owns 306,809 shares of the medical instruments supplier’s stock valued at $8,301,000 after buying an additional 54,920 shares during the period. Canvas Wealth Advisors LLC boosted its position in DENTSPLY SIRONA by 126.5% during the 4th quarter. Canvas Wealth Advisors LLC now owns 326,298 shares of the medical instruments supplier’s stock valued at $6,245,000 after buying an additional 182,234 shares during the period. Finally, Nisa Investment Advisors LLC boosted its position in DENTSPLY SIRONA by 89.6% during the 4th quarter. Nisa Investment Advisors LLC now owns 54,397 shares of the medical instruments supplier’s stock valued at $1,041,000 after buying an additional 25,705 shares during the period. Hedge funds and other institutional investors own 95.70% of the company’s stock.

DENTSPLY SIRONA Stock Up 1.2%

Shares of NASDAQ XRAY opened at $16.70 on Friday. The company has a current ratio of 1.25, a quick ratio of 0.84 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a 12 month low of $12.16 and a 12 month high of $28.44. The firm has a market capitalization of $3.33 billion, a PE ratio of -8.07, a price-to-earnings-growth ratio of 1.80 and a beta of 0.92. The firm has a fifty day simple moving average of $14.41 and a two-hundred day simple moving average of $17.34.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings results on Thursday, May 8th. The medical instruments supplier reported $0.43 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.29 by $0.14. The company had revenue of $879.00 million during the quarter, compared to analyst estimates of $854.75 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. DENTSPLY SIRONA’s quarterly revenue was down 7.8% compared to the same quarter last year. During the same period last year, the business earned $0.42 EPS. Equities analysts expect that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Friday, April 11th. Investors of record on Friday, March 28th were paid a $0.16 dividend. The ex-dividend date was Friday, March 28th. This represents a $0.64 annualized dividend and a dividend yield of 3.83%. DENTSPLY SIRONA’s payout ratio is -14.10%.

Wall Street Analysts Forecast Growth

Several brokerages have weighed in on XRAY. Robert W. Baird dropped their price target on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a “neutral” rating for the company in a research report on Friday, February 28th. Jefferies Financial Group cut shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and dropped their price target for the company from $30.00 to $20.00 in a research report on Thursday, January 23rd. UBS Group dropped their price target on shares of DENTSPLY SIRONA from $27.00 to $25.00 and set a “buy” rating for the company in a research report on Friday, May 9th. Needham & Company LLC reissued a “hold” rating on shares of DENTSPLY SIRONA in a research report on Thursday, March 13th. Finally, Mizuho dropped their price target on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a “neutral” rating for the company in a research report on Thursday, March 13th. Eleven investment analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and a consensus price target of $20.36.

Insider Buying and Selling

In other DENTSPLY SIRONA news, Director Gregory T. Lucier purchased 15,142 shares of the firm’s stock in a transaction that occurred on Monday, March 3rd. The stock was bought at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the purchase, the director now directly owns 81,971 shares in the company, valued at $1,353,341.21. The trade was a 22.66% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.50% of the stock is owned by company insiders.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.